SARASIN CUTS CLARIANT ESTIMATES AFTER SALE

A A

Clariant restructuring still has some way to go, following divestment of pharmaceutical fine chemicals, says Sarasin. Cuts '06 EPS estimates by nearly 19% to account for expected book loss to CHF1 per share, but sees no impact on '07 estimates and DFCF price target of CHF18.

Newratings (http://www.newratings.com/analyst_news/article_1261907.html)